A neuroleptic malignant syndrome case with haloperidol depot

Abstract

The development of depot antipsychotics are facilitated incompatible patient's treatment process for in terms of chronic disease course. One of the disadvantages of depot antipsychotics, having various advantages and disadvantages, neuroleptic malignant syndrome (NMS) rate is higher than the oral form. NMS, rare but can be fatal, is an idiosyncratic reaction characterized by confusion, hyperthermia, autonomic dysfunction, muscle rigidity after use of neuroleptics. In this case, a schizophrenia patient used to haloperidol depot, named Haldol Decanoate in abroad used since 1986 (Europe, US) but recently introduced in Turkey, with NMS was reported.